GZPHF's PB Ratio is ranked better than 64.55% of 110
companies
in the Medical Distribution industry
Industry Median: 0.98
vs GZPHF: 0.87
During the past 12 months, Guangzhou Baiyunshan Pharmaceutical Holdings Co's average Book Value Per Share Growth Rate was 4.90% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 5.60% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 7.60% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 11.60% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Guangzhou Baiyunshan Pharmaceutical Holdings Co was 26.80% per year. The lowest was -1.60% per year. And the median was 7.80% per year.
Back to Basics: PB Ratio
Guangzhou Baiyunshan Pharmaceutical Holdings Co (OTCPK:GZPHF) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Guangzhou Baiyunshan Pharmaceutical Holdings Co PB Ratio Related Terms
Guangzhou Baiyunshan Pharmaceutical Holdings Co PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guangzhou Baiyunshan Pharmaceutical Holdings Co PB Ratio Chart
Guangzhou Baiyunshan Pharmaceutical Holdings Co Annual Data
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Guangzhou Baiyunshan Pharmaceutical Holdings Co PB Ratio vs Medical Distribution Industry
Guangzhou Baiyunshan Pharmaceutical Holdings Co PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Guangzhou Baiyunshan Pharmaceutical Holdings Co (GZPHF) has a PB Ratio of 0.66 as of Jul. 08, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Guangzhou Baiyunshan Pharmaceutical Holdings Co and its competitors. This is 63% below median its historical median of 1.77. Over the past decade, Guangzhou Baiyunshan Pharmaceutical Holdings Co's PB Ratio has ranged from 0.81 to 3.79. According to the industry distribution chart, Guangzhou Baiyunshan Pharmaceutical Holdings Co ranks #39 out of 110 companies in the Medical Distribution industry, placing it in the top 35.5%.
Is Guangzhou Baiyunshan Pharmaceutical Holdings Co's PB Ratio too high?
Guangzhou Baiyunshan Pharmaceutical Holdings Co's current PB Ratio of 0.66 is 63% below median its 10-year median of 1.77. Over the past 10 years, this metric has ranged from a low of 0.81 to a high of 3.79. The Medical Distribution industry median PB Ratio is 0.98. Guangzhou Baiyunshan Pharmaceutical Holdings Co's value of 0.66 is 32.7% below this industry median. Based on the distribution chart, Guangzhou Baiyunshan Pharmaceutical Holdings Co ranks #39 out of 110 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Guangzhou Baiyunshan Pharmaceutical Holdings Co has a GF Score™ of 67/100, reflecting its overall financial health beyond just this single metric.
How does Guangzhou Baiyunshan Pharmaceutical Holdings Co's PB Ratio compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Guangzhou Baiyunshan Pharmaceutical Holdings Co ranks #39 out of 110 companies for PB Ratio. This puts Guangzhou Baiyunshan Pharmaceutical Holdings Co in the upper half of its industry. The industry median PB Ratio is 0.98. Guangzhou Baiyunshan Pharmaceutical Holdings Co's value of 0.66 is 32.7% below this benchmark. Historically, Guangzhou Baiyunshan Pharmaceutical Holdings Co's own PB Ratio has ranged from 0.81 to 3.79 over the past decade. While the company's 10-year median is 1.77 vs. the industry median of 0.98, Guangzhou Baiyunshan Pharmaceutical Holdings Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Distribution company?
The median PB Ratio among Medical Distribution companies is 0.98, based on 110 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Guangzhou Baiyunshan Pharmaceutical Holdings Co's current PB Ratio of 0.66 is 32.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Guangzhou Baiyunshan Pharmaceutical Holdings Co and its competitors. For the Medical Distribution industry, the median PB Ratio is 0.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Guangzhou Baiyunshan Pharmaceutical Holdings Co's current PB Ratio is 0.66, which is 63% below median its own 10-year median of 1.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guangzhou Baiyunshan Pharmaceutical Holdings Co stock overvalued right now?
Guangzhou Baiyunshan Pharmaceutical Holdings Co (GZPHF) has a current PB Ratio of 0.66. The stock's GF Value™ is $3.25, compared to a current price of $2.34 — trading 28% below its estimated fair value. The current PB Ratio is 0.66, which is 63% below median its 10-year median of 1.77 and 32.7% below the Medical Distribution industry median of 0.98. Guangzhou Baiyunshan Pharmaceutical Holdings Co's overall GF Score™ is 67/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Guangzhou Baiyunshan Pharmaceutical Holdings Co (GZPHF), the current PB Ratio is 0.66 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Guangzhou Baiyunshan Pharmaceutical Holdings Co (GZPHF) Overvalued in 2026?
Based on GuruFocus' analysis, Guangzhou Baiyunshan Pharmaceutical Holdings Co stock appears to be undervalued.
The current stock price of $2.34 is trading 28% below its estimated GF Value™ of $3.25.
Key valuation signals for GZPHF:
PB Ratio: 0.66 (63% below median its 10-year median of 1.77)
GF Value™: $3.25 vs. price of $2.34 (28% below fair value)
Industry Position: 32.7% below the Medical Distribution median (#39 of 110)
No single metric tells the full story. See the GZPHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Guangzhou Baiyunshan Pharmaceutical Holdings Co Business Description
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is engaged in the pharmaceutical and healthcare industry, focusing on the development of a full industrial chain covering research, manufacturing, and distribution. The group operates through five reportable segments. The Modern Chinese Medicine segment involves the R&D, manufacturing, and sale of proprietary Chinese and natural medicines. The Chemical Pharmaceutical Technology segment focuses on chemical drugs, APIs, and intermediates. The Natural Beverages segment produces and sells health-oriented beverage products. The Pharmaceutical Commerce segment is engaged in the wholesale, retail, and import/export of medicines and medical devices. The Other Segments include biotechnology innovation, consumer health, and medical services.
67GF Score
Get the complete analysis for GZPHF
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GZPHF has been successfully added to your 
